Longwood Capital Partners »

Apellis Pharmaceuticals shares owned by Longwood Capital Partners

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Longwood Capital Partners from 13F filings

Historical chart of Longwood Capital Partners investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Longwood Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Longwood Capital Partners

Quarter filed Position value Share count Share price at filing
2023-09-30 $9.3M 245k 38.04
2023-06-30 $27M 298k 91.10
2023-03-31 $19M 291k 65.96
2022-12-31 $11M 218k 51.71
2022-09-30 $38M 554k 68.30
2022-06-30 $25M 554k 45.22
2022-03-31 $28M 554k 50.81
2021-12-31 $25M 535k 47.28
2021-09-30 $2.5M 76k 32.95
2021-06-30 $10M 161k 63.20
2021-03-31 $4.9M 113k 42.91
2020-12-31 $9.6M 167k 57.20
2020-09-30 $5.0M 167k 30.17
2020-06-30 $6.2M 190k 32.66
2020-03-31 $5.6M 210k 26.79
2019-12-31 $5.7M 188k 30.62
2018-06-30 $3.7M 168k 22.00